Alzheimer’s drugs offer little benefit, major review finds – and the reasons go deeper than the science

Alzheimer’s drugs offer little benefit, major review finds – and the reasons go deeper than the science

Summary

Alzheimer’s research shows what happens when funding pressures and vested interests corrupt the pursuit of scientific truth.

Description

Alzheimer’s research shows what happens when funding pressures and vested interests corrupt the pursuit of scientific truth.

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage